论文部分内容阅读
目的:观察并分析脑梗塞运用银杏达莫并用奥扎格雷静滴治疗的临床效果。方法::随机选取2013年5月至2015年6月间于该院接受治疗的84例脑梗塞患者为研究对象,分为2组,对照组采取银杏达莫进行临床治疗,观察组患者则在此基础上家有那个奥扎格雷静滴进行临床治疗,两组各纳入病患42例。结果:对比两组患者的临床治疗总有效率以及神经功能缺损评分,结果显示观察组均具有明显优异性(P<0.05)。对比不良反应发生概率,结果未见明显差异(P>0.05)。结论:采用银杏达莫联合奥扎格雷静滴治疗脑梗塞临床疗效较为理想,且不会导致患者出现明显不良反应,更利于改善患者的神经功能,促进患者康复,故值得临床推广应用。
Objective: To observe and analyze the clinical effect of intravenous infusion of ozagrel in patients with cerebral infarction. METHODS: A total of 84 patients with cerebral infarction who were treated in the hospital from May 2013 to June 2015 were randomly divided into two groups. The patients in the control group were treated with gingko-damo and the patients in the observation group were treated with Based on this home that Ozagrel intravenous infusion of clinical treatment, 42 patients were included in both groups. Results: The total effective rate of clinical treatment and neurological deficit scores were compared between the two groups. The results showed that the observation group had obvious superiority (P <0.05). Compare the incidence of adverse reactions, the results showed no significant difference (P> 0.05). Conclusion: The clinical efficacy of intravenous injection of gingko-damo combined with ozagrel in the treatment of cerebral infarction is ideal, and will not cause obvious adverse reactions in patients, more conducive to improving the neurological function of patients and promote the rehabilitation of patients, it is worthy of clinical promotion and application.